If the drug companies win this fight over Part B, the entire country will be the loser. Drug costs will continue to rise with impunity — and drive up health insurance premiums. Medicare will pay more, and all of us — especially the six million seniors who have large co-pays for Part B drugs — will pay more out of pocket. And their new-found political muscle would prevent any future laws or regulations to limit drug prices.
Read Full Article »
